Lupin Ltd has received approval for its Hydrocortisone Valerate Cream USP, 0.2% from the United States Food and Drug Administration (U.S. FDA).
Lupin's Hydrocortisone Valerate Cream USP, 0.2% is the generic version of Westcort® cream, 0.2% of Sun Pharmaceutical Industries, Inc. It is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses in adult patients.
Hydrocortisone Valerate Cream USP, 0.2%, (RLD: Westcort®) had an annual sales of approximately US$ 15 million in the US (IQVIA MAT March 2019).
Shares of LUPIN LTD. was last trading in BSE at Rs.734.35 as compared to the previous close of Rs. 748.25. The total number of shares traded during the day was 89916 in over 2266 trades.
The stock hit an intraday high of Rs. 750 and intraday low of 722.25. The net turnover during the day was Rs. 65705016.